A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer
Mayo Clinic
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Stanford University
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)